Get the Stockscreener App
87.18
0.53%
0.46
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $87.18, with a volume of 1.19M.
It is up +0.53% in the last 24 hours and up +7.80% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$86.72
Open:
$86.525
24h Volume:
1.19M
Relative Volume:
0.75
Market Cap:
$42.49B
Revenue:
$10.19B
Net Income/Loss:
$1.05B
P/E Ratio:
41.43
EPS:
2.1044
Net Cash Flow:
$1.38B
1W Performance:
+5.51%
1M Performance:
+7.80%
6M Performance:
+7.15%
1Y Performance:
-5.21%
1-Day Range:
$86.01
$87.20
1-Week Range:
$82.22
$87.64
52-Week Range:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC vs ISRG, BDX, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
87.18 | 42.27B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
503.51 | 180.01B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
176.48 | 50.25B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
47.51 | 39.67B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.26 | 37.45B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alcon (ALC) - The Globe and Mail
Wells Fargo Upgrades Alcon (ALC) - Nasdaq
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday - Benzinga
2026 DallasCISO ORBIE Awards Recognize Top Security Executives - GlobeNewswire Inc.
Barclays Maintains Rating for Alcon (ALC) and Raises Price Targe - GuruFocus
Today's Analyst Upgrade for Alcon (ALC) with New Price Target | - GuruFocus
Wells Fargo upgrades Alcon stock rating on new product growth By Investing.com - Investing.com Nigeria
Nvidia To Rally More Than 53%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Alcon Inc. (NYSE:ALC) Q4 2025 Earnings Call Transcript - Insider Monkey
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcon, First Solar, Five Below, Joby Aviation, Spotify, Trade Desk, U.S. Bancorp, and More - 24/7 Wall St.
Lensar® provides update on pending acquisition by Alcon - marketscreener.com
Lensar® Provides Update On Pending Acquisition By Alcon - TradingView
LENSAR Updates Timeline for Pending Alcon Acquisition Review - TipRanks
Alcon Posts Strong Q4 2025 Sales Growth and Robust Cash Generation - The Globe and Mail
LENSAR-Alcon deal closing pushed to first half of 2026 - Investing.com
ALC.SW Alcon Inc. (SIX) ends CHF64.26 25 Feb 2026: heavy volume, earnings focus - Meyka
Lensar, Alcon still working on US FTC second request, aim to close before July - MLex
LENSAR Provides Update on Alcon Acquisition Status - Intellectia AI
LENSAR-Alcon deal closing pushed to first half of 2026 By Investing.com - Investing.com South Africa
LENSAR® Provides Update on Pending Acquisition by Alcon - The Manila Times
LENSAR Provides Update, Expects Alcon Acquisition to Close in H1 2026 Pending FTC Approval - TradingView
LENSAR, Inc. Provides Update on Acquisition Status by Alcon Research, LLC - Quiver Quantitative
Tariffs, Competition Ding Alcon’s Future - WFMZ.com
Alcon (SWX:ALC) Margin Decline Tests Bullish Growth Narrative Despite Higher FY 2025 Revenue - simplywall.st
Alcon Inc (ALC) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amid Market ... By GuruFocus - Investing.com Canada
Alcon (ALC) Q4 2025 Earnings Call Transcript - The Globe and Mail
Alcon (ALC) Reports Strong Q4 2025 Performance with 7% Sales Gro - GuruFocus
Alcon targets 5%–7% sales growth in 2026 while expanding Unity platform and launching new IOLs - MSN
Alcon (ALC) Receives New "Buy" Rating and Raised Price Target fr - GuruFocus
Alcon: Markets forgive Q4 miss for a healthy 2026 outlook - marketscreener.com
Alcon Inc (ALC) Stock Price Up 3.55% on Feb 25 - GuruFocus
Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y - The Globe and Mail
Alcon Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:ALC) 2026-02-25 - Seeking Alpha
Alcon Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Eye-care group Alcon expects product launches to drive 2026 sales, profitability - WKZO
Earnings Flash (ALC.L) Alcon Inc. Reports FY25 Revenue $10.32B - marketscreener.com
Alcon's FY25 Net Income Falls; Sales Up - marketscreener.com
Alcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Alcon (ALC) Reports Q4 Revenue Slightly Below Expectations - GuruFocus
Alcon (ALC) Shares Fall After Q4 2025 Earnings Miss - GuruFocus
Alcon slips as Q4 financial results miss on both lines - MSN
Alcon’s 2025 Annual Report Showcases Innovation-Led Growth and Strategic Eye-Care Expansion - TipRanks
Alcon Q4 Core Earnings, Sales Rise - marketscreener.com
Earnings Flash (ALC) Alcon Posts Q4 Core EPS $0.78, vs. FactSet Est of $0.79 - marketscreener.com
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales - The AI Journal
Ophthalmic Operating Tables Market Is Going to Boom | Alcon • B. Braun Melsungen AG • Geuder AG - openPR.com
Earnings Preview: Alcon - Benzinga
Alcon AG expected to post earnings of 78 cents a shareEarnings Preview - TradingView
How Alcon Inc. Ordinary Shares stock reacts to weak economyWeekly Trend Recap & Expert Approved Trade Ideas - mfd.ru
Alcon Inc. (ALC.SW, SIX) earnings 24 Feb 2026: watch margins and guidance - Meyka
Gear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.82%
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):